Investment Year



Nutromics is on a mission to revolutionize diagnostics through our DNA-based sensor platform. This is a breakthrough technology combining multiple DNA-based sensors with minimally invasive microneedles that can track multiple crucial targets continuously and in real time, giving clinicians critical, personalized insights.


70% of clinical decisions are made using lab diagnostics. However, clinicians today are hampered by insufficient and delayed lab diagnostics. Real-time trend data is critical for the treatment and diagnosis of hundreds of dynamic targets and fast-moving conditions.

Nutromics’ Lab-on-a-patch TM unlocks continuous and real-time diagnostic monitoring for these targets, providing clinicians with critical, personalised insights for the first time.